In Part 2 of this Exclusive Interview, Dr. Osama Hamdy talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about ways to work within cultural traditions to improve nutrition and eating habits thus affecting diabetes management.
Read More »Current Interview: Mark Molitch
Dr. Mark Molitch is the Martha Leland Sherwin Professor of Medicine at Northwestern in the Division of Endocrinology, Metabolism and Molecular Medicine. Dr. Molitch has been active in clinical research in diabetes, focusing on diabetic nephropathy, and other areas of endocrinology.
Read More »Mark Molitch Full Interview
In this Exclusive Interview, Dr. Mark Molitch talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about how doctors can educate patients on nutrition and diet issues, the advances in diabetes technology, and the complexities of diabetes multi-drug therapies.
Read More »Mark Molitch Transcript
Transcript coming soon.
Read More »Mark Molitch Part 1, Introduction and Educating Patients
In part 1 of this Exclusive Interview, Dr. Mark Molitch talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about teaching medical students about the specifics of nutrition as it relates to diabetes management.
Read More »Mark Molitch Part 2, The Future of Diabetes Treatment
In part 2 of this Exclusive Interview, Dr. Mark Molitch shares his thoughts about technology, the latest meds, and what's coming down the pike in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.
Read More »Mark Molitch Part 3, Hyperglycemia After Transplantation
In part 3 of this Exclusive Interview, Dr. Mark Molitch talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about his ADA presentation on resulting diabetes diagnoses or hyperglycemia following islet pancreatic transplant surgery.
Read More »Mark Molitch Part 4, SGLT2 Inhibitors and Diabetes
In part 4 of this Exclusive Interview, Dr. Mark Molitch shares his thoughts on the latest diabetes drug class, SGLT2, in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.
Read More »Mark Molitch Part 5, Diabetic Renal Failure
In part 5 of this Exclusive Interview, Dr. Mark Molitch explains the changes in diabetes care that have resulted in the dramatic decrease in renal failure in diabetes patients in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.
Read More »Mark Molitch Part 6, Post- and Pre-Kidney Transplant Treatment
In part 6 of this Exclusive Interview, Dr. Mark Molitch explains the diabetes treatment objective in patients who have undergone a transplant in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.